Amgen Slashes the Price of a Promising Cholesterol Drug

The drug maker cut the list price of the drug Repatha by 60 percent in an effort to increase sales, which have been meager.
By KATIE THOMAS from NYT Health https://ift.tt/2Sj05PK
via IFTTT
Repatha (Drug), Drugs (Pharmaceuticals), Prices (Fares, Fees and Rates), Praluent (Drug), Cholesterol
Source The New York Times
Làm đẹp Blog 247